Berkshire Hathaway Inc.
BRK-B
$471.63
+0.26%
Berkshire Hathaway Inc. is a diversified holding company with subsidiaries engaged in insurance, freight rail transportation, utilities, manufacturing, services, and retailing. It is a unique and iconic conglomerate, distinguished by its long-term value investing philosophy, decentralized operational model, and massive equity portfolio managed by Warren Buffett and Charlie Munger. The current investor narrative revolves around the company's succession planning post-Buffett, its ability to deploy its enormous cash reserves into value-accretive acquisitions or share buybacks, and its performance as a defensive, low-beta holding in a volatile market, especially given its recent underperformance relative to the S&P 500.…
BRK-B
Berkshire Hathaway Inc.
$471.63
Investment Opinion: Should I buy BRK-B Today?
Rating & Thesis: Hold. BRK-B is a high-quality, defensive conglomerate trading at a reasonable valuation, but it lacks near-term catalysts for outperformance and is mired in a persistent downtrend. The single analyst with coverage maintains a 'Buy' rating, but the absence of a broad consensus target price underscores the stock's unique, under-followed nature.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is not excessive at a trailing P/E of 16.19x, which is below its historical average. Second, profitability remains strong with a net margin of 20.37% and an ROE of 9.33%. Third, the balance sheet is impeccable, with a debt-to-equity of 0.19 and $25B in TTM free cash flow. Fourth, the stock's defensive beta of 0.62 offers portfolio stability, though this has recently meant dramatic underperformance. The implied 'upside' is more about capital preservation and long-term compounding than short-term price appreciation.
Risks & Conditions: The two biggest risks are continued revenue/earnings deterioration and a failure to deploy capital effectively post-Buffett. This Hold would upgrade to a Buy if: 1) the stock price falls to or below its 52-week low of $455, offering a more compelling margin of safety, or 2) the company announces a major accretive acquisition or initiates a substantial share buyback program. It would downgrade to a Sell if quarterly revenue decline accelerates beyond 10% or if the technical breakdown below $455 is sustained. Relative to its own history and the defensive quality it offers, the stock is fairly valued, not cheap enough to be a compelling Buy nor expensive enough to warrant a Sell.
Sign up to view all
BRK-B 12-Month Price Forecast
The 12-month outlook for BRK-B is one of muted expectations with a defensive skew. The base case (60% probability) of range-bound trading between $470 and $500 is most likely, reflecting its status as a high-quality but slow-growing holding company. The bull case requires a specific capital allocation catalyst that has been elusive. The bear case, while lower probability, is grounded in tangible macro risks to its core businesses. The stance is neutral due to the offsetting forces of attractive fundamentals and poor technicals. Confidence is medium because the company's size and complexity make near-term outcomes difficult to predict. The stance would upgrade to bullish on a sustained move above $517 (52-week high) or a major capital return announcement. It would turn bearish on a confirmed breakdown below the $455 support level on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Berkshire Hathaway Inc.'s 12-month outlook, with a consensus price target around $613.12 and implied upside of +30.0% versus the current price.
Average Target
$613.12
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$377 - $613
Analyst target range
Analyst coverage for BRK-B appears limited, with data indicating only one analyst providing estimates. The estimated EPS for the next period is $21.72, with a range from $21.09 to $22.34. Revenue is estimated at $367.15 billion. The institutional ratings data shows a consistent 'Buy' rating from UBS across multiple dates in 2024 and 2025. However, the lack of a broad consensus target price and the minimal number of analysts suggest limited traditional Wall Street coverage. This is typical for Berkshire Hathaway, as its size, complexity, and unique structure lead many analysts to focus on its underlying businesses rather than the holding company. The implication of limited coverage is that the stock may be less influenced by short-term analyst sentiment shifts, but it also means price discovery is driven more by macroeconomic factors, the company's own results, and the actions of large institutional investors rather than a crowded field of sell-side research.
Bulls vs Bears: BRK-B Investment Factors
The investment debate for BRK-B hinges on a clash between its undeniable fundamental strength and its glaring lack of momentum. The bull case is anchored in a fortress balance sheet (D/E 0.19), massive cash flow ($25B FCF), a defensive low-beta profile (0.62), and a valuation that is not stretched at a 16.2x trailing P/E. The bear case is driven by sustained revenue decline (-7.13% YoY), severe relative underperformance (-34.5% vs. SPY), a lack of near-term catalysts, and a persistent technical downtrend. Currently, the bearish evidence from price action and growth concerns holds stronger sway in the market, as reflected in the stock's performance. The single most important tension is whether the company's legendary capital allocation prowess can overcome its massive scale to find value-accretive deployments for its cash, thereby reversing the growth narrative and removing the succession overhang. The resolution of this tension will determine if the stock transitions from a defensive value trap to a compounding machine once again.
Bullish
- Fortress Balance Sheet & Cash Flow: Berkshire's financial position is exceptionally strong, with a debt-to-equity ratio of only 0.19 and a current ratio of 6.75, indicating minimal leverage and high liquidity. The company generates massive free cash flow of $25.04 billion (TTM), providing ample dry powder for value-accretive acquisitions or share buybacks, especially in a market downturn.
- Defensive, Low-Beta Profile: With a beta of 0.62, BRK-B is approximately 38% less volatile than the broader market, making it a classic defensive holding. This characteristic is valuable in volatile markets, as evidenced by its 1-year underperformance of -6.26% versus the S&P 500's +28.21% gain, suggesting it has not participated in the recent speculative rally and may be relatively insulated from a correction.
- Attractive Valuation Near Historical Lows: The stock trades at a trailing P/E of 16.19x, which is below its 5-year historical average and near the lower end of its historical range (as low as 4.75x, as high as 62.40x). Trading at $474.47, it is only 7.7% above its 52-week low of $455.19, positioning it in a potential value zone for long-term investors.
- High Profitability & Capital Efficiency: The company maintains robust profitability with a net margin of 20.37% in Q4 2025 and a Return on Equity (ROE) of 9.33%. Despite volatile quarterly earnings, the underlying operating businesses consistently generate strong cash flows, supporting the conglomerate's intrinsic value.
Bearish
- Sustained Revenue Decline & Underperformance: Q4 2025 revenue declined 7.13% year-over-year to $94.23 billion, continuing a volatile and weakening top-line trend. This fundamental softness is reflected in the stock's severe 1-year underperformance of -34.47% relative to the S&P 500, indicating a lack of growth catalysts and waning investor interest.
- Lack of Clear Growth Catalysts: The company faces challenges in deploying its massive cash hoard into acquisitions large enough to move the needle, given its size. With no dividend and limited analyst coverage (only 1 analyst providing estimates), there are few near-term catalysts to reverse the negative price momentum and attract growth-oriented capital.
- Earnings Volatility & Forward PE Expansion: Quarterly net income is highly volatile, ranging from $4.6B to $30.8B over the past year, largely driven by investment gains/losses. The forward P/E of 22.27x is significantly higher than the trailing 16.19x, implying the market expects a sharp earnings decline, which aligns with the estimated next-period EPS of $21.72.
- Technical Downtrend & Weak Momentum: The stock is in a clear and sustained downtrend, down 6.03% over the past 3 months and 7.65% over the past 6 months. It consistently trades below its 52-week high of $516.85, with weak relative strength (-6.50% over 1 month), indicating persistent selling pressure and a lack of buyer conviction.
BRK-B Technical Analysis
The stock is in a sustained downtrend, with a 1-year price change of -6.26% as of the latest data, significantly underperforming the S&P 500's +28.21% gain. Currently trading at $474.47, it sits approximately 7.7% above its 52-week low of $455.19 and 8.2% below its 52-week high of $516.85, positioning it in the lower quartile of its annual range. This suggests the stock is approaching a potential value zone, but the persistent downtrend indicates strong selling pressure and a lack of bullish catalysts. Recent momentum remains weak, with the stock down 0.19% over the past month and down 6.03% over the past three months, confirming the negative longer-term trend. The 1-month relative strength versus the S&P 500 is -6.50%, highlighting continued underperformance. Key technical levels are clearly defined, with immediate support at the 52-week low of $455.19 and resistance near the 52-week high of $516.85. A breakdown below $455 would signal a new leg down, while a sustained move above $517 could indicate a trend reversal. The stock's beta of 0.62 confirms its defensive, low-volatility nature, being approximately 38% less volatile than the broader market, which is a key characteristic for risk-averse investors.
Beta
0.62
0.62x market volatility
Max Drawdown
-14.9%
Largest decline past year
52-Week Range
$455-$517
Price range past year
Annual Return
-6.2%
Cumulative gain past year
| Period | BRK-B Return | S&P 500 |
|---|---|---|
| 1m | -0.3% | +5.4% |
| 3m | -3.3% | +10.9% |
| 6m | -6.3% | +11.0% |
| 1y | -6.2% | +28.1% |
| ytd | -5.1% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRK-B Fundamental Analysis
Revenue for Q4 2025 was $94.23 billion, representing a year-over-year decline of 7.13%. This follows a volatile quarterly pattern: Q3 2025 revenue was $94.97B, Q2 was $98.88B, and Q1 was $83.29B, indicating inconsistent top-line performance. The revenue decline is a concern, though segment data shows the Insurance Group ($26.41B), Pilot Travel Centers ($21.21B), and Service/Retailing businesses ($21.37B) were the largest contributors in the latest period. The company remains highly profitable, with Q4 2025 net income of $19.20 billion. The gross margin for the quarter was 23.01%, and the net margin was a robust 20.37%. Profitability has been volatile quarter-to-quarter, with net margins ranging from 5.53% in Q1 2025 to 32.43% in Q3 2025, largely influenced by investment gains/losses. The balance sheet and cash flow position are exceptionally strong. The company boasts a healthy current ratio of 6.75 and a very low debt-to-equity ratio of 0.19, indicating minimal financial leverage. Trailing twelve-month free cash flow is a substantial $25.04 billion, providing immense internal funding capacity for investments or buybacks. Return on equity (ROE) stands at 9.33%, reflecting efficient use of shareholder capital.
Quarterly Revenue
$94.2B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$25.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRK-B Overvalued?
Given the consistently positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 16.19x, while the forward PE is 22.27x. The higher forward multiple suggests the market anticipates an earnings decline, which aligns with the estimated EPS of $21.72 for the next period, down from the recent quarterly EPS of $8.90 (annualized run-rate is higher, but earnings are lumpy). Comparing to industry averages is complex due to Berkshire's conglomerate structure, but its trailing PE of 16.2x is generally in line with or at a slight discount to the broader market, especially considering its quality and defensive profile. Historically, the stock's own valuation provides more context. The current trailing PE of 16.19x is below its 5-year historical average seen in the data, which has frequently been in the mid-to-high teens and even single digits during periods of high earnings. For instance, the PE ratio was as low as 4.75x in Q1 2023 and as high as 62.40x in Q1 2025. Trading near the lower end of its historical PE band suggests the stock is not overvalued and may be pricing in near-term headwinds.
PE
16.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -52x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Berkshire's primary financial risk is not solvency—its balance sheet is rock-solid—but earnings volatility and top-line pressure. Quarterly net income has fluctuated wildly from $4.6B to $30.8B over the past year, driven by unpredictable investment gains/losses, making forward earnings difficult to forecast. Furthermore, Q4 2025 revenue declined 7.13% YoY, indicating potential softness across its diversified operating segments. While the company's low debt (D/E 0.19) and high liquidity (Current Ratio 6.75) mitigate default risk, dependence on continued profitability from cyclical businesses like insurance, railroads, and utilities presents an operational headwind in an economic downturn.
Market & Competitive Risks: The key market risk is continued valuation compression and persistent underperformance. The stock's beta of 0.62 confirms its defensive nature, but this has translated into dramatic underperformance (-34.5% relative strength over 1 year) in a growth-oriented market. Trading at a forward P/E of 22.27x, which anticipates lower earnings, there is risk of further multiple contraction if the market rotates away from value or if earnings disappoint. Competitive risks are diffuse but real across its many subsidiaries, from insurance (Geico) facing pricing pressure to BNSF rail competing with trucks. The lack of broad analyst coverage (only 1 analyst) also means price discovery is less efficient and potentially more prone to large swings on company-specific news.
Worst-Case Scenario: The worst-case scenario involves a perfect storm: a deep economic recession simultaneously pressures earnings at its core operating companies (insurance claims rise, rail volumes fall, utility demand drops) and triggers significant mark-to-market losses in its massive equity portfolio. This could lead to consecutive quarters of steep earnings declines, forcing a reevaluation of its 'permanent' holding value. Combined with a failed leadership transition post-Buffett, investor confidence could erode sharply. Quantifying the downside, the stock could realistically retest and break below its 52-week low of $455.19. A further 10% decline from that level to around $410 is plausible in a severe bear case, representing a total potential loss of approximately -13.6% from the current price of $474.47 to $410, or -4.1% just to the 52-week low.
FAQ
The key risks are, in order of severity: 1) Capital Allocation Risk: The inability to deploy its $25B+ in annual free cash flow into value-creating investments, leading to stagnant growth and a valuation discount. 2) Succession Risk: Uncertainty surrounding the post-Buffett/Munger era could lead to a permanent de-rating of the stock's premium. 3) Operational/Economic Risk: Its core businesses (insurance, railroads, utilities) are cyclical; a recession could pressure earnings, as hinted by the recent 7.13% YoY revenue decline. 4) Performance Risk: The stock's low beta (0.62) means it may continue to dramatically underperform a rising market, as seen in its -34.5% 1-year relative strength, testing investor patience.
The 12-month forecast presents three scenarios with associated probabilities. The Base Case (60% probability) sees the stock trading between $470 and $500, reflecting range-bound action as a defensive holding with stable operations. The Bull Case (25% probability) targets $516 to $540, driven by a major capital deployment announcement or a smooth succession resolution. The Bear Case (15% probability) warns of a drop to $430-$455 if macro conditions deteriorate and earnings weaken. The base case is most likely, assuming the status quo persists: strong cash generation but no major catalysts to break the stock out of its current technical downtrend and valuation range.
BRK-B appears fairly valued relative to its own history and defensive profile. The trailing P/E ratio of 16.19x is below its 5-year historical average and not excessive for a company of its quality and profitability (20.37% net margin). However, the forward P/E of 22.27x suggests the market expects earnings to decline, which aligns with the estimated EPS of $21.72. Compared to the broader market, it trades at a discount, but this is typical for its slower-growth, conglomerate structure. The valuation implies the market is paying a fair price for steady, defensive earnings but is not assigning a premium for growth, reflecting concerns over capital deployment and succession.
BRK-B is a good stock to buy for a specific type of investor: one with a very long-term horizon seeking a defensive, low-volatility holding with a margin of safety. Its trailing P/E of 16.19x is reasonable, and its fortress balance sheet (D/E 0.19) limits downside risk. However, with a 1-year return of -6.26% and severe underperformance versus the market, it lacks near-term momentum and growth catalysts. For investors looking for aggressive growth or income, it is not a good buy. For those building a conservative, long-term portfolio, it can be a good foundational holding, especially if purchased on weakness closer to its 52-week low of $455.
BRK-B is unequivocally suitable only for long-term investment, with a suggested minimum holding period of 5-10 years. Its low beta (0.62) and lack of near-term catalysts make it a poor vehicle for short-term trading. The investment thesis is based on the long-term compounding of intrinsic value through the retained earnings of its subsidiaries and the capital allocation skill of its management. Short-term price movements are noisy and driven by quarterly investment gains/losses. For long-term investors, volatility can provide entry points, but the stock should be viewed as a permanent holding in a diversified portfolio, not a tactical trade.